本页面由Tiger Trade Technology Pte. Ltd.提供服务

再鼎医药

18.00
+0.49002.80%
盘后18.000.00000.00%17:58 EDT
成交量:69.19万
成交额:1,246.00万
市值:19.98亿
市盈率:-11.23
高:18.46
开:18.07
低:17.85
收:17.51
52周最高:44.34
52周最低:15.96
股本:1.11亿
流通股本:1.09亿
量比:0.65
换手率:0.63%
股息:- -
股息率:- -
每股收益(TTM):-1.6026
每股收益(LYR):-1.6026
净资产收益率:-22.56%
总资产收益率:-12.16%
市净率:2.79
市盈率(LYR):-11.23

数据加载中...

2020/06/17

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/04/29

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/19

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/16

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/11

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/03

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]